Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tankovic

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|August 1, 1995
Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutationsS Ouabdesselam, D C Hooper, J Tankovic, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
Development of fluoroquinolone resistance in Enterococcus faecalis and role of mutations in the DNA gyrase gyrA geneJ Tankovic, F Mahjoubi, P Courvalin, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 1999
In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gram-negative bacilli and Enterococcus faecalisJ Tankovic, R Bachoual, S Ouabdesselam, et al.
Alimentary Pharmacology & Therapeutics|May 1, 2001
Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapyJ Tankovic, D Lamarque, C Lascols, et al.
Pathologie-Biologie|October 20, 2001
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapyJ Tankovic, D Lamarque, C Lascols, et al.
FEMS Microbiology Letters|September 22, 1998
Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCRE Sevin, D Lamarque, J C Delchier, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|January 5, 2002
Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coliR Bachoual, S Ouabdesselam, F Mory, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
Evaluation of nitrofurantoin combination therapy of metronidazole-sensitive and -resistant Helicobacter pylori infections in miceP J Jenks, R L Ferrero, J Tankovic, et al.
Journal Des Maladies Vasculaires|January 1, 1996
[Antibiotic-impregnated prostheses: eclectic indications]D Melliere, S Zaouche, J P Becquemin, et al.
British Journal of Pharmacology|April 29, 1998
Induction of nitric oxide synthase in vivo and cell injury in rat duodenal epithelium by a water soluble extract of Helicobacter pyloriD Lamarque, J Kiss, J Tankovic, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|August 1, 1995
Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutationsS Ouabdesselam, D C Hooper, J Tankovic, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
Development of fluoroquinolone resistance in Enterococcus faecalis and role of mutations in the DNA gyrase gyrA geneJ Tankovic, F Mahjoubi, P Courvalin, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 1999
In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gram-negative bacilli and Enterococcus faecalisJ Tankovic, R Bachoual, S Ouabdesselam, et al.
Alimentary Pharmacology & Therapeutics|May 1, 2001
Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapyJ Tankovic, D Lamarque, C Lascols, et al.
Pathologie-Biologie|October 20, 2001
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapyJ Tankovic, D Lamarque, C Lascols, et al.
FEMS Microbiology Letters|September 22, 1998
Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCRE Sevin, D Lamarque, J C Delchier, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|January 5, 2002
Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coliR Bachoual, S Ouabdesselam, F Mory, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
Evaluation of nitrofurantoin combination therapy of metronidazole-sensitive and -resistant Helicobacter pylori infections in miceP J Jenks, R L Ferrero, J Tankovic, et al.
Journal Des Maladies Vasculaires|January 1, 1996
[Antibiotic-impregnated prostheses: eclectic indications]D Melliere, S Zaouche, J P Becquemin, et al.
British Journal of Pharmacology|April 29, 1998
Induction of nitric oxide synthase in vivo and cell injury in rat duodenal epithelium by a water soluble extract of Helicobacter pyloriD Lamarque, J Kiss, J Tankovic, et al.
Pageof 4